The ACT device paired with a previous phone.
LifeWatch, a Swiss remote cardiac monitoring company that has been connecting to mobile phones since 2009, has received FDA clearance for a new version of its Ambulatory Cardiac Telemetry (ACT) system that will run on Android devices. Currently, the system runs on Microsoft Windows phones. Patients use the mobile software to answer a couple...
Research firm Tractica predicts that worldwide unit shipments of clinical and non-clinical connected wearable patches will grow to 12.3 million per year by 2020. Last year, annual shipments were just 67,000. The market for such connected patches, Tractica predicts, will hit $3.3 billion per year.
Tractica describes the category as including "patches, tattoos, or small devices that are affixed to...
Vital Connect's HealthPatch, which partnered with LifeWatch last month
Swiss remote cardiac monitoring company LifeWatch has received FDA 510(k) clearance for LifeWatch VSP (Vital Signs Patch), the company's adhesive patch for remote patient monitoring.
"Being small in size, easy to affix, comfortable to wear and far less restrictive and cumbersome than numerous wired devices currently used,...
Medical device giant Medtronic is in the final stages of acquiring peel-and-stick medical sensor company Corventis for north of $150 million, MobiHealthNews has learned. While neither company has publicly commented on the deal, it is expected to be officially announced some time in the next few weeks. (Update: I've heard conflicting reports from sources on the price of the deal since publishing...
LifeWatch's CardGuard PMP4 Suite of Devices
A recently published study in the Journal of Medical Internet Research found that mobile phone-based heart failure telemonitoring was an easy to use solution that offered immediate feedback to both patients and clinicians. The small study -- just 22 heart failure patients used the mobile phone-based monitoring system for six months -- required patients...
CardioComm ECG Monitor
CardioComm Solutions and TZ Medical inked a device integration and distribution deal that brings the pair into the the mobile cardiac telemetry (MCT) electrocardiographic (ECG) and arrhythmia management market. CardioComm will integrate TZM's Aera CT MCT monitor into its GEMS software to create a new offering called GEMS Aera CT. It will be an extension of CardioComm's...
Gemalto-owned Cinterion has inked a deal with TZ Medical to embed a cellular wireless chip into the medical device company's heart arrhythmia monitoring device, Aera-CT, which the companies expect to launch in North America during the third quarter. TZ explains that the device can monitor patients for up to 28 days and also enables care providers to communicate with patients via the device.
The...
Big news for anyone concerned about reimbursement issues for wireless health: CardioNet, which leverages wireless technology to diagnose and monitor cardiac arrhythmias, announced this week that the Centers for Medicare and Medicaid Services (CMS) has established a national rate for the technical component of mobile cardiovascular telemetry (MCOT). CardioNet said that the rate is approximately $...
AT&T has inked a deal with eCardio Diagnostics to provide wireless connectivity to the arrhythmia monitoring company's near real-time cardiac monitoring devices. eCardio’s monitoring devices enable heart patients to recover at home rather than spend additional time in the hospital and aim to help reduce re-admissions among heart patients.
According to the companies' release, "eCardio has...
Jupiter Research analyst Anthony Cox divides wireless remote monitoring into two discrete buckets: Fundamental heart monitoring and on-going management of chronic diseases. While Jupiter's current and near-term forecast for these two categories favors the CardioNets, LifeWatches and eCardios of the world, Cox believes that longterm the larger user base and bigger revenues will come from managing...
